Why Does Tirzepatide Cause Diarrhoea — and What Can You Do About It?

What is tirzepatide actually doing to the gut?

Tirzepatide works by activating two receptors in the body: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). Both are naturally occurring gut hormones, and when tirzepatide mimics them, the effects ripple through the digestive system in ways that go beyond appetite suppression.

The most significant of these is a slowing of gastric emptying, food stays in the stomach longer before passing into the small intestine. That slower transit time changes the rhythm of the whole digestive tract. In some people, the net effect is constipation; in others, particularly early in treatment, the gut responds with faster movement further down the intestine, drawing less fluid back from stool and producing loose or watery motions. The NHS tirzepatide medicines page lists diarrhoea as one of the common side effects, common meaning it affects between one in ten and one in hundred users in clinical reporting, though real-world rates vary.

It is also worth knowing that the GLP-1 receptor sits throughout the gastrointestinal tract, not just in the stomach. Activating it affects intestinal secretion and motility at multiple points, which is partly why Mounjaro causes diarrhoea in some people even when they are eating very little. For a fuller picture of how the medicine behaves in the body, the broader pattern of Mounjaro side effects covers the complete GI profile.

When does tirzepatide-related diarrhoea tend to happen, and how long does it last?

Timing follows a predictable pattern for most people. The most noticeable GI symptoms (including diarrhoea) tend to cluster in the first one to two weeks after starting a new dose. That is when the body is adapting to a higher level of receptor activation than it has seen before. After the adaptation period, symptoms usually settle, often considerably. The same process can repeat, at a milder level, after each dose increase through the titration schedule.

A few things tend to make early diarrhoea worse: eating large meals (the stomach is already working more slowly, so a big bolus of food overwhelms it), eating high-fat meals (fat slows gastric emptying further and is harder to digest at pace), and drinking alcohol. Smaller portions, lower-fat choices and adequate plain fluids are the practical tools most people find helpful during adjustment.

Persistent diarrhoea beyond two to three weeks at a stable dose, or diarrhoea severe enough to disrupt daily life, is worth flagging to your prescriber. The practical side of managing tirzepatide and diarrhoea covers day-to-day strategies in more detail, and the question of whether tirzepatide directly causes diarrhoea situates the evidence carefully for anyone wanting to read further.

When should diarrhoea prompt you to get medical help?

Most diarrhoea on tirzepatide is uncomfortable rather than dangerous. However, there are clear situations where you should seek prompt attention rather than waiting it out.

Contact your GP or NHS 111 if: diarrhoea is severe or has lasted more than a few days without improvement; you are showing signs of dehydration (dark urine, dizziness, significantly reduced urine output, rapid heartbeat); you have severe, persistent stomach pain, especially pain that radiates to your back, with or without vomiting. That last combination is significant because, in January 2026, the MHRA issued a Drug Safety Update highlighting acute pancreatitis as an infrequent but serious known side effect of GLP-1 medicines; the symptoms to watch for are exactly that pattern of severe abdominal pain reaching the back. You can report any suspected side effect directly through the MHRA Yellow Card scheme, patients can do this themselves, and it helps regulators track real-world safety signals.

If you are not sure whether what you are experiencing is typical or needs attention, our team is reachable seven days a week. Contacting us through the support page gets you to a clinician, not a chatbot.

Does diarrhoea mean you should stop taking tirzepatide?

Not automatically, and not without speaking to your prescriber first. Stopping abruptly means losing the clinical benefit, and in most cases the symptom can be managed by adjusting meal habits or, where appropriate, pausing a planned dose increase while the gut settles.

A prescriber will weigh the symptom against its impact on your daily life, your hydration status and your overall progress. That is a clinical conversation, not one to resolve by simply stopping. If you started treatment through a service that doesn't provide ongoing aftercare, that gap matters, it's a reason people look for clinical support that runs through the whole treatment, not just the initial prescription. Our prescribers discuss side effects and suitability from the first consultation onwards; you can read more about how the clinical team approaches that at our clinical team page.

For anyone weighing up whether to start treatment, the treatment consultation page is where that conversation begins. And if you are comparing the gut-effect profiles of different GLP-1 medicines, why tirzepatide causes nausea covers the overlapping mechanism for that symptom.